• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • English
    • Français
  • Canada
    • Répertoire du site Sandoz
Sandoz : A Novartis Division
  • Our Work
    • What We Do
    • Quality Generics
    • Biopharmaceuticals
    • Specialty Products
  • About Us
    • Who We Are
    • Corporate Responsibility
    • Doing Business Responsibly
    • Contact Us
    • Grants, Donations and Sponsorships
  • Products
    • Consumers
    • Patients
    • Healthcare Professionals
    • Patient Support Programs
  • News
    • Media Releases
    • Media Resource Center
    • Stay Up-To-Date
  • Careers
    • Available Positions
    • Diversity & Inclusion
    • Our Benefits
  • Sandoz-Connect Portal
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
  • Jump to Comments
Stories/Medicines

Sandoz Canada has the necessary supply to ensure access to the S.O.S. Naloxone(TM) Hydrochloride Injection in response to the opioid crisis

Following the mention in certain media outlets regarding the unavailability of the Naloxone antidote against opioid overdoses, we wish to inform of that Sandoz Canada has the necessary supply to ensure access to S.O.S. Naloxone™ Hydrochloride Injection and it is available to all Canadian pharmacies that wish to obtain it.

Nov 16, 2017

Following the mention in certain media outlets regarding the unavailability of the Naloxone antidote against opioid overdoses, we wish to inform that -Sandoz Canada has the necessary supply to ensure access to S.O.S. Naloxone™ Hydrochloride Injection and it is available to all Canadian pharmacies that wish to obtain it. This injectable medicine is manufactured by Sandoz Canada at its Boucherville facility in Quebec and is available without a prescription at the pharmacy counter. Sandoz Canada is known for having the most reliable supply chain in the industry, and the company’s inventories can supply the market and meet the growing needs.

S.O.S NaloxoneTM Hydrochloride Injection may be administered by a bystander, by family, friends or a healthcare professional to a patient who is experiencing or suspected of overdosing on opioids, reversing the effects before medical aid arrives. Emergency medical assistant should still be requested immediately when an opioid overdose is suspected.

A pamphlet with patient information, as well as step-by-step instructions and illustrations sur the administration process is offered with the product. A demonstration video is equally available explaining the correct way of administering Naloxone. To view it, click here (external link).

S.O.S. NaloxoneTM Hydrochloride Injection is available in ampoules each containing 0.4 mg / mL naloxone hydrochloride.

Sandoz is discovering new ways to improve and extend people’s lives. We pioneer novel approaches to help people access high-quality medicine. This is how we contribute to improving society’s ability to support growing healthcare needs and costs.

If you have any questions, do not hesitate to contact us.

The Communications Team

Sandoz Canada

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Medicines

New indication approved for Sandoz Erelzi® (etanercept) in the Treatment of Psoriatic Arthritis

Erelzi_logo
Medicines

Erelzi™ (etanercept), by Sandoz, is now available for patients in Canada for the treatment of multiple inflammatory diseases.

Medicines

Bringing medication and medical care to people in crisis – the work of Americares

You are here

  1. Home ›
  2. Medicines ›

Sandoz Canada

  • Notre travail
  • Our Work
  • À propos de nous
  • About Us
  • Produits
  • Products
  • Nouvelles
  • News
  • Carrières
  • Careers
  • Contactez-nous
  • Contact Us
  • Nous trouver
  • Office Locations
  • Rester à jour
  • Stay up to date

Subscribe to Sandoz

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • RSS
  • Sandoz Site Directory
© 2023 Sandoz AG

This site is intended for an audience in Canada

  • Termes d'utilisation
  • Terms of Use
  • Politique sur la vie privée
  • Privacy Policy
  • Terms of Trade
  • Return Policy
  • Politique d'achat
  • Politique de retour
  • Cookie Settings